title: [Prevention of ostial obstruction after microendoscopic endonasal dacryocystorhinostomy].
abstract: Ostial dilatator was created to prevent recurrence and improve efficacy of microendoscopic endonasal dacryocystorhinostomy. Proposed technique was for the first time used in 52 patients. Postoperative results were analyzed: recovery was achieved in 78% of cases, improvement - in 22%. In a control group (51 patients) we used conventional technique, recovery was achieved in 67% of patients and improvement in 28%, in 5% recurrence occurred. The use of ostial dilatator resulted in microendoscopic endonasal dacryocystorhinostomy efficacy improvement.
authors.forename: V G
authors.initials: VG
authors.lastname: Beloglazov
authors.forename: E L
authors.initials: EL
authors.lastname: At'kova
authors.forename: G A
authors.initials: GA
authors.lastname: Abdurakhmanov
authors.forename: N N
authors.initials: NN
authors.lastname: Krakhovetskiĭ
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003607:Dacryocystitis / Q000601:surgery*; D003608:Dacryocystorhinostomy / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D004106:Dilatation / Q000295:instrumentation*; D004867:Equipment Design; D005260:Female; D006801:Humans; D007767:Lacrimal Duct Obstruction / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009296:Nasal Cavity / Q000601:surgery; D057605:Natural Orifice Endoscopic Surgery / Q000379:methods*; D011183:Postoperative Complications / Q000503:physiopathology / Q000517:prevention & control; D055502:Secondary Prevention; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents